Inventor
ESTER FERNANDEZ-SALAS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds16%
C07KPeptides16%
A61KPreparations for medical, dental or toiletry purposes11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
12,145,944Imidazopyrimidines as EED inhibitors and the use thereof202411,970,543Anti-CD39 antibodies and use thereof202411,466,028Fused 1,4-oxazepines as BET protein degraders202211,332,518Immuno-based botulinum toxin serotype A activity assays202211,267,822BET bromodomain protein degraders with cleavable linkers202211,261,240Immuno-based botulinum toxin serotype A activity assays2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to UNIV MICHIGAN REGENTS (3)· patent assignee history
2022Patents assigned to ALLERGAN INC (2)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to ARCUS BIOSCIENCES INC (1)· patent assignee history
2024Patents assigned to UNIV MICHIGAN (1)· patent assignee history
2024Patents assigned to WUXI BIOLOGICS IRELAND LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV MICHIGAN REGENTS | 3 | 2022–2024 |
| ALLERGAN INC | 2 | 2022 |
| ARCUS BIOSCIENCES INC | 1 | 2024 |
| UNIV MICHIGAN | 1 | 2024 |
| WUXI BIOLOGICS IRELAND LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2024 |